Clinical Trials Directory

Trials / Completed

CompletedNCT04775017

Delirium in Covid-19: Germany-wide Covid-19 Intensive Register

Status
Completed
Phase
Study type
Observational
Enrollment
2,398 (actual)
Sponsor
Charite University, Berlin, Germany · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The global pandemic caused by the SARS-CoV-2 virus is confronting the German health system with a novel pathogen. This means that a timely evaluation of all available results is required. In the field of intensive care in particular, there are significant gaps in knowledge, particularly with regard to delirium. In this respect, this study also serves directly to investigate the pathways of delirium outcome in COVID-19 patients.

Conditions

Timeline

Start date
2021-01-01
Primary completion
2022-02-21
Completion
2022-08-31
First posted
2021-03-01
Last updated
2024-10-29

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT04775017. Inclusion in this directory is not an endorsement.

Delirium in Covid-19: Germany-wide Covid-19 Intensive Register (NCT04775017) · Clinical Trials Directory